M
MRSN
Mersana Therapeutics Inc
This stock has been delisted.
News
Press Releases
Financial Reports
Profile
Dow Jones·01/06 22:08
*News On Mersana Therapeutics Inc. (MRSN) Now Under DAWN
TipRanks·01/06 14:49
Mersana Therapeutics Completes Merger and Delists from Nasdaq
Reuters·12/11/2025 21:15
Serina Therapeutics Appoints Dr. Joshua Thomas as Vice President and Head of Chemistry
Seeking Alpha·12/10/2025 15:26
AstraZeneca: A Rare Compound Growth Opportunity In Biopharma
Seeking Alpha·11/15/2025 20:15
Key deals this week: Merck, Day One Biopharmaceutical, ABN AMRO, Revvity, Centerspace and more
TipRanks·11/15/2025 06:01
Mersana Therapeutics Faces High Stakes with Potential Day One Biopharmaceuticals Merger Delays
TipRanks·11/15/2025 03:57
Mersana Therapeutics to be Acquired by Day One
Reuters·11/14/2025 20:19
BUZZ-Nasdaq biotech index hits record high, set to gain nearly 5% this week
Seeking Alpha·11/14/2025 20:00
Catalyst Watch: Spotlight on Nvidia's outlook, Walmart's strategy, and Fedspeak
Dow Jones·11/14/2025 14:25
Mersana Therapeutics Cut to Neutral From Buy by Guggenheim
Benzinga·11/14/2025 14:15
Guggenheim Downgrades Mersana Therapeutics to Neutral
TipRanks·11/14/2025 13:55
Morning Movers: Cidara skyrockets following Merck buyout offer
Same Industry
Name/Symbol
Change%
Price
Contact Us
Contact Number :+852 3852 8500Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hkOnline Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2026 Webull Securities Limited. All rights reserved.